Determination of methotrexate in human urine at nanomolar levels by high-performance liquid chromatography with column switching.
An high-performance liquid chromatographic method with column switching for the detection of less than 4 ng of methotrexate in the urine of oncologic nurses is described. Urine samples were purified by solid-phase extraction on silica-bonded phenyl columns, eluting impurities with ethyl acetate. After elution from the column, the analyte was concentrated ten-fold, evaporating the solvent. On a strong anion-exchange column (Nucleosil 100 SB), methotrexate was separated from the remaining interfering substances, was then switched to a reversed-phase column (LiChrospher 100 RP-18e), and finally eluted by a linear gradient in a solvent system consisting of ammonium formate buffer (pH 2.7) and acetonitrile. Absorbance was monitored at 310 nm. This method has proved to be suitable for detecting traces of methotrexate in urine in order to individualize risks and to reduce further the occupational safety hazard for hospital personnel.
Department of Internal Medicine I, University of Vienna, Austria.
R M
RM
Mader
B
B
Rizovski
G G
GG
Steger
H
H
Rainer
R
R
Proprentner
R
R
Kotz
D001859:Bone Neoplasms / Q000188:drug therapy; D002851:Chromatography, High Pressure Liquid; D005615:Freezing; D006801:Humans; D007202:Indicators and Reagents; D008727:Methotrexate / Q000627:therapeutic use / Q000652:urine*; D009729:Nursing; D016273:Occupational Exposure; D012516:Osteosarcoma / Q000188:drug therapy; D011786:Quality Control
D007202:Indicators and Reagents; D008727:Methotrexate